Juan Manuel Alonso‐Domínguez

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Leukemia · 2021 · 169 citations · Full text

Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Blood · 2019 · 88 citations

Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

Valentín García‐Gutiérrez, Alejandro Luna, Juan Manuel Alonso‐Domínguez et al. · Blood Cancer Journal · 2021 · 43 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +6

A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring <i>KMT2A</i> or <i>NPM1</i> Alterations

Elias Jabbour, Emma Searle, Maher Abdul‐Hay et al. · Blood · 2023 · 42 citations

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

Bruno Paiva, María‐Belén Vídriales, Amparo Sempere et al. · Leukemia · 2021 · 40 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +11